Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer

Part of paid clinical trials in Stanford, California.

Sponsor
Stanford University
Study ID
NCT00230308
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Through this study, we hope to learn more about the mechanisms, which may contribute to development and progression of head and neck cancer. The long-term goal of this study will be to develop new strategies and drugs for the diagnosis and treatment of head and neck cancer.

Key Dates

Start date
Apr 2, 2002
Status verified
Dec 2025
Primary completion
Jun 30, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
500 participants (estimated)

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford University School of MedicineStanfordCalifornia94305
Nikita Bedi
[email protected]
650-723-5957
Cancer Clinical Trials Office
(650) 498-7061
Quynh-Thu Le (SUB_INVESTIGATOR)
Willard E Fee Jr (SUB_INVESTIGATOR)
Zijie Sun (SUB_INVESTIGATOR)
Jan Matthijs van de Rijn (SUB_INVESTIGATOR)
Dr Michael Kaplan (SUB_INVESTIGATOR)
John B Sunwoo (PRINCIPAL_INVESTIGATOR)

Find similar trials in Stanford, CA

By condition
Head and neck cancer
By specialty
OncologyENT
By research site
Stanford University School of Medicine· Stanford, CA

Related Studies